Role of PACAP and VIP in astroglial functions

Peptides

Volumn 28, Issue 9, 2007, Pages 1753-1760

  Masmoudi Kouki, Olfa ^a,b,c   Gandolfo, Pierrick ^a,b,d   Castel, Hélène ^a,b,d   Leprince, Jérôme ^a,b,d   Fournier, Alain ^d,e   Dejda, Agnieszka ^a,b,d,f   Vaudry, Hubert ^a,b,d   Tonon, Marie Christine ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE ROUEN   (France)

^c Laboratory of Physiology of the Nutrition   (Tunisia)

^d International Associated Laboratory Samuel de Champlain   (France)

^e INRS INSTITUT ARMAND FRAPPIER   (Canada)

^f INSTITUTE OF MEDICAL BIOLOGY   (Poland)

Author keywords

Astrocytes; Gliotransmitters; Neurotrophic factors; Plasticity; Stem cell

Indexed keywords

GLYCOGEN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; NEUROPEPTIDE; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2;

ARTICLE; BIOSYNTHESIS; BRAIN; CELL FUNCTION; CELL PROLIFERATION; HUMAN; MACROGLIA; NERVE CELL PLASTICITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STEM CELL;

ANIMALS; ASTROCYTES; CELL PROLIFERATION; GLYCOGEN; HUMANS; MODELS, BIOLOGICAL; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; VASOACTIVE INTESTINAL PEPTIDE;

EID: 34548408187     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.05.015     Document Type: Article

References (84)

1. Alho H., Kolmer M., Harjuntausta T., and Helen P. Increased expression of diazepam binding inhibitor in human brain tumors. Cell Growth Differ 6 (1995) 309-314
2. Allaman I., Pellerin L., and Magistretti P.J. Protein targeting to glycogen mRNA expression is stimulated by noradrenaline in mouse cortical astrocytes. Glia 30 (2000) 382-391
3. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48 (1998) 301-331
4. Ashur-Fabian O., Giladi E., Brenneman D.E., and Gozes I. Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides. J Mol Neurosci 9 (1997) 211-222
5. Blondel O., Collin C., McCarran W.J., Zhu S., Zamostiano R., Gozes I., et al. A glia-derived signal regulating neuronal differentiation. J Neurosci 20 (2000) 8012-8020
6. A receptors. Neuropharmacology 30 (1991) 1387-1389
7. Brenneman D.E., Phillips T.M., Festoff B.W., and Gozes I. Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann NY Acad Sci 814 (1997) 167-173
8. Brenneman D.E., Hauser J.M., Spong C., and Phillips T.M. Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity. Neuropeptides 36 (2002) 271-280
9. Brenneman D.E., Phillips T.M., Hauser J., Hill J.M., Spong C.Y., and Gozes I. Complex array of cytokines released by vasoactive intestinal peptide. Neuropeptides 37 (2003) 111-119
10. Brown D.R. Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity. Mol Cell Neurosci 15 (2000) 465-475
11. Bürgi B., Lichtensteiger W., Lauber M.E., and Schlumpf M. Ontogeny of diazepam binding inhibitor/acyl-CoA binding protein mRNA and peripheral benzodiazepine receptor mRNA expression in the rat. J Neuroendocrinol 11 (1999) 85-100
12. Cardinaux J.R., and Magistretti P.J. Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-β and C/EBP-δ in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism. J Neurosci 16 (1996) 919-929
13. Cazillis M., Gonzalez B.J., Billardon C., Lombet A., Fraichard A., Samarut J., et al. VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells. Eur J Neurosci 19 (2004) 798-808
14. Compère V., Li S., Leprince J., Tonon M.C., Vaudry H., and Pelletier G. Effect of intracerebroventricular administration of the octadecaneuropeptide on the expression of pro-opiomelanocortin, neuropeptide Y and corticotropin-releasing hormone mRNAs in rat hypothalamus. J Neuroendocrinol 15 (2003) 197-203
15. Compère V., Li S., Leprince J., Tonon M.C., Vaudry H., and Pelletier G. In vivo action of a new octadecaneuropeptide (ODN) antagonist on gonadotropin-releasing hormone gene expression in the male rat brain. Neuroscience 125 (2004) 411-415
16. Compère V., Li S., Leprince J., Tonon M.C., Vaudry H., and Pelletier G. In vivo action of a new octadecaneuropeptide antagonist on neuropeptide Y and corticotropin-releasing hormone mRNA levels in rat. Mol Brain Res 141 (2005) 156-160
17. Dejda A., Sokolowska P., and Nowak J.Z. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol Report 57 (2005) 307-320
18. Dejda A., Jozwiak-Bebenista M., and Nowak J.Z. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures. Ann NY Acad Sci 1070 (2006) 220-225
19. Dufes C., Alleaume C., Montoni A., Olivier J.C., and Muller J.M. Effects of the vasoactive intestinal peptide (VIP) and related peptides on glioblastoma cell growth in vitro. J Mol Neurosci 21 (2003) 91-102
20. Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., et al. Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J Neurochem 91 (2004) 1231-1243
21. Ferrero P., Santi M.R., Conti-Tronconi B., Costa E., and Guidotti A. Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc Natl Acad Sci USA 83 (1986) 827-831
22. 2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Eur J Pharmacol 322 (1997) 275-281
23. Grimaldi M., and Cavallaro S. Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11 (1999) 2767-2772
24. Guidotti A., Corda M.G., and Costa E. Strategies for the isolation and characterization of an endogenous effector of the benzodiazepine recognition sites. Adv Biochem Psychopharmacol 38 (1983) 95-103
25. Hall A. Rho GTPases the actin cytoskeleton. Science 279 (1998) 509-514
26. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 (1998) 265-270
27. Hashimoto H., Kunugi A., Arakawa N., Shintani N., Fujita T., Kasai A., et al. Possible involvement of a cyclic AMP-dependent mechanism in PACAP-induced proliferation and ERK activation in astrocytes. Biochem Biophys Res Commun 311 (2003) 337-343
28. Ikeda T., Iijima N., Munekawa K., Ishihara A., Ibata Y., and Tanaka M. Functional retinal input stimulates expression of astroglial elements in the suprachiasmatic nucleus of postnatal developing rat. Neurosci Res 47 (2003) 39-45
29. Jaworski D.M. Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors, and in response to acute intracranial injury. Cell Tissue Res 300 (2000) 219-230
30. Joo K.M., Chung Y.H., Kim M.K., Nam R.H., Lee B.L., Lee K.H., et al. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol 476 (2004) 388-413
31. Leprince J., Oulyadi H., Vaudry D., Masmoudi O., Gandolfo P., Patte C., et al. Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. Eur J Biochem 268 (2001) 6045-6057
32. Magistretti P.J. VIP neurons in the cerebral cortex. Trends Pharmacol Sci 11 (1990) 250-254
33. Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Fournier A., Patte-Mensah C., et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J 17 (2003) 17-27
34. Masmoudi-Kouki O., Gandolfo P., Leprince J., Vaudry D., Pelletier G., Fournier A., et al. PACAP stimulates biosynthesis and release of endozepines from rat astrocytes. Ann NY Acad Sci 1070 (2006) 411-416
35. Mei Y.A., Vaudry D., Basille M., Castel H., Fournier A., Vaudry H., et al. PACAP inhibits delayed rectifier potassium current via a cAMP/PKA transduction pathway: evidence for the involvement of Ik in the anti-apoptotic action of PACAP. Eur J Neurosci 19 (2004) 1446-1458
36. Mercer A., Ronnholm H., Holmberg J., Lundh H., Heidrich J., Zachrisson O., et al. PACAP promotes neural stem cell proliferation in adult mouse brain. J Neurosci Res 76 (2004) 205-215
37. Meyer D.K., Fischer C., Becker U., Gottsching I., Boutillier S., Baermann C., et al. Pituitary adenylyl cyclase-activating polypeptide 38 reduces astroglial proliferation by inhibiting the GTPase RhoA. J Biol Chem 280 (2005) 25258-25266
38. Miettinen H., Kononen J., Haapasalo H., Helen P., Sallinen P., Harjuntausta T., et al. Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation. Cancer Res 55 (1995) 2691-2695
39. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L., et al. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164 (1989) 567-574
40. Moroo I., Tatsuno I., Uchida D., Tanaka T., Saito J., Saito Y., et al. Pituitary adenylate cyclase activating polypeptide (PACAP) stimulates mitogen-activated protein kinase (MAPK) in cultured rat astrocytes. Brain Res 795 (1998) 191-196
41. Nagashima A.C., Giacomini D., Castro C.P., Pereda M.P., Renner U., Stalla G.K., et al. Transcriptional regulation of interleukin-6 in pituitary folliculo-stellate TtT/GF cells. Mol Cell Endocrinol 201 (2003) 47-56
42. Nakatani M., Seki T., Shinohara Y., Taki C., Nishimura S., Takaki A., et al. Pituitary adenylate cyclase-activating peptide (PACAP) stimulates production of interleukin-6 in rat Müller cells. Peptides 27 (2006) 1871-1876
43. Nishimoto M., Furuta A., Aoki S., Kudo Y., Miyakawa H., and Wada K. PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells. Glia 55 (2007) 317-327
44. Ohno F., Watanabe J., Sekihara H., Hirabayashi T., Arata S., Kikuyama S., et al. Pituitary adenylate cyclase-activating polypeptide promotes differentiation of mouse neural stem cells into astrocytes. Regul Peptides 126 (2005) 115-122
45. Ohtaki H., Nakamachi T., Dohi K., Aizawa Y., Takaki A., Hodoyama K., et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci USA 103 (2006) 7488-7493
46. Papadopoulos V., Guarneri P., Kreuger K.E., Guidotti A., and Costa E. Pregnenolone biosynthesis in C6-2B glioma cell mitochondria: regulation by a mitochondrial diazepam binding inhibitor receptor. Proc Natl Acad Sci USA 89 (1992) 5113-5117
47. Papadopoulos V., Lecanu L., Brown R.C., Han Z., and Yao Z.X. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience 138 (2006) 749-756
48. Patte C., Vaudry H., Desrues L., Gandolfo P., Strijdveen I., Lamacz M., et al. The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes. FEBS Lett 362 (1995) 106-110
49. Perez V., Bouschet T., Fernandez C., Bockaert J., and Journot L. Dynamic reorganization of the astrocyte actin cytoskeleton elicited by cAMP and PACAP: a role for phosphatidyl inositol 3-kinase inhibition. Eur J Neurosci 21 (2005) 26-32
50. Pilzer I., and Gozes I. VIP provides cellular protection through a specific splice variant of the PACAP receptor: a new neuroprotection target. Peptides 27 (2006) 2867-2876
51. Pilzer I., and Gozes I. A splice variant to PACAP receptor that is involved in spermatogenesis is expressed in astrocytes. Ann New York Acad Sci 1070 (2006) 484-490
52. Reglodi D., Somogyvari-Vigh A., Vigh S., Kozicz T., and Arimura A. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31 (2000) 1411-1417
53. Robberecht P., Woussen-Colle M.C., Vertongen P., De Neef P., Hou X., Salmon I., et al. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors. Peptides 15 (1994) 661-665
54. Rosenberg P.A., and Li Y. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neurosci Lett 200 (1995) 93-96
55. Said S.I., and Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 169 (1970) 1217-1218
56. Scolari MJ, Acosta GB. D-serine: a new word in the glutamatergic neuro-glial language. Amino Acids 2007, doi:10.1007/s00726-006-0481-0.
57. Sharma A., Walters J., Gozes Y., Fridkin M., Brenneman D., Gozes I., et al. A vasoactive intestinal peptide antagonist inhibits the growth of glioblastoma cells. J Mol Neurosci 17 (2001) 331-339
58. Sherwood N.M., Krueckl S.L., and McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr Rev 21 (2000) 619-670
59. Shioda S., Ozawa H., Dohi K., Mizushima H., Matsumoto K., Nakajo S., et al. PACAP protects hippocampal neurons against apoptosis: involvement of JNK/SAPK signaling pathway. Ann NY Acad Sci 865 (1998) 111-117
60. Shioda S., Ohtaki H., Suzuki R., Nakamachi T., Takenoya F., Dohi K., et al. Prevention of delayed neuronal cell death by PACAP and its molecular mechanism. Nippon Yakurigaku Zasshi 123 (2004) 243-252
61. Shioda S., Ohtaki H., Nakamachi T., Dohi K., Watanabe J., Nakajo S., et al. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann NY Acad Sci 1070 (2006) 550-560
62. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A., and Costa E. Isolation and characterization of a rat brain triakontatetraneuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site. J Neurochem 53 (1989) 1276-1284
63. Sorg O., and Magistretti P.J. Characterization of the glycogenolysis elicited by vasoactive intestinal peptide, noradrenaline and adenosine in primary cultures of mouse cerebral cortical astrocytes. Brain Res 563 (1991) 227-233
64. Sorg O., and Magistretti P.J. Vasoactive intestinal peptide and noradrenaline exert long-term control on glycogen levels in astrocytes: blockade by protein synthesis inhibition. J Neurosci 12 (1992) 4923-4931
65. Suzuki S., Tanaka K., Nogawa S., Nagata E., Ito D., Dembo T., et al. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 19 (1999) 1256-1262
66. Suzuki R., Arata S., Nakajo S., Ikenaka K., Kikuyama S., and Shioda S. Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. Mol Brain Res 115 (2003) 10-20
67. Tatsuno I., Gottschall P.E., and Arimura A. Specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat cultured astrocytes: Molecular identification and interaction with vasoactive intestinal peptide (VIP). Peptides 12 (1991) 617-621
68. Tatsuno I., and Arimura A. Pituitary adenylate cyclase-activating polypeptide (PACAP) mobilizes intracellular free calcium in cultured rat type-2, but not type-1, astrocytes. Brain Res 662 (1994) 1-10
69. i response to PACAP at a single cell level. Ann NY Acad Sci 805 (1996) 613-619
70. Tong Y., Toranzo D., and Pelletier G. Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides 20 (1991) 33-40
71. Vallejo I., and Vallejo M. Pituitary adenylate cyclase-activating polypeptide induces astrocyte differentiation of precursor cells from developing cerebral cortex. Mol Cell Neurosci 21 (2002) 671-683
72. Vaudry D., Gonzalez B.J., Basille M., Fournier A., and Vaudry H. Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc Natl Acad Sci USA 96 (1999) 9415-9420
73. Vaudry D., Gonzalez B.J., Basille M., Pamantung T.F., Fontaine M., Fournier A., et al. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc Natl Acad Sci USA 97 (2000) 13390-13395
74. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., and Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol Rev 52 (2000) 269-324
75. Vaudry D., Pamantung T.F., Basille M., Rousselle C., Fournier A., Vaudry H., et al. PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci 15 (2002) 1451-1460
76. Vaudry D., Rousselle C., Basille M., Falluel-Morel A., Pamantung T.F., Fontaine M., et al. Pituitary adenylate cyclase-activating polypeptide protects rat cerebellar granule neurons against ethanol-induced apoptotic cell death. Proc Natl Acad Sci USA 99 (2002) 6398-6403
77. Vaudry D., Falluel-Morel A., Basille M., Pamantung T.F., Fontaine M., Fournier A., et al. Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. J Neurosci Res 72 (2003) 303-316
78. Vertongen P., d'Haens J., Michotte A., Velkeniers B., van Rampelbergh J., Svoboda M., et al. Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors. Peptides 16 (1995) 713-719
79. Vertongen P., Camby I., Darro F., Kiss R., and Robberecht P. VIP and pituitary adenylate cyclase activating polypeptide (PACAP) have an antiproliferative effect on the T98G human glioblastoma cell line through interaction with VIP2 receptor. Neuropeptides 30 (1996) 491-496
80. Volterra A., and Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6 (2005) 626-640
81. Watanabe J., Ohba M., Ohno F., Kikuyama S., Nakamura M., Nakaya K., et al. Pituitary adenylate cyclase-activating polypeptide-induced differentiation of embryonic neural stem cells into astrocytes is mediated via the beta isoform of protein kinase C. J Neurosci Res 84 (2006) 1645-1655
82. Won C.L., and Oh Y.S. cAMP-induced stellation in primary astrocyte cultures with regional heterogeneity. Brain Res 887 (2000) 250-258
83. Zupan V., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., Robberecht P., et al. Involvement of pituitary adenylate cyclase-activating polypeptide II vasoactive intestinal peptide 2 receptor in mouse neocortical astrocytogenesis. J Neurochem 70 (1998) 2165-2173
84. Zusev M., and Gozes I. Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP. Regul Peptides 123 (2004) 33-41